Can a “health food” eaten by millions really be dangerous?
Canola oil and its derivative, rapeseed, are primary suspects for the exceptionally high incidence of Asian lung cancer.
According to mainstream media though, canola oil is “good for the heart” offering viable monounsaturated fats similar to olive oil. Sadly, much of what we hear in the mainstream media and various “health” blogs has been influenced by aggressive marketing tactics of big food companies.
For this reason, it is critical to know what websites to avoid and where you can go to get trustworthy and accurate health information.
In order to understand how canola oil came into the marketplace, some historical background is needed.
A Bit of History on Canola Oil
We can trace olive oil back to olives and sesame seed oil back to sesame seeds, so wouldn’t it make sense that canola oil would come from canola seeds? Well, it’s not the case. There is no natural canola plant that produces canola oil.
In the late 1960s canola oil was invented in Canada. The oil was cheap to manufacture and a dominant ingredient in many processed foods. A derivative of the rapeseed plant, which is part of the mustard family of plants, canola oil has been hybridized to eliminate the lethal erucic acid found in rapeseed.
Olive oil was the product of choice among those who were health conscious; however, it was quite expensive to mass produce. So the food industry, needing a more affordable substitute, started selling rapeseed oil. Unfortunately, the rapeseed oil caused muscular heart lesions.
The erucic acid found in rapeseed oil is naturally poisonous to the degree that insects avoid it. Rapeseed oil is also the source of the notorious chemical warfare agent, mustard gas. The US banned rapeseed in 1956 when thousands of soldiers and civilians experienced blistered lungs and skin. Rapeseed oil also lubricated steam engines and ships due to its unique ability to adhere to wet metal.
In 1964, the food industry collaborated with both the chemical and nuclear industries in an attempt to reduce the toxicity levels of rapeseed. It took the food industry over a decade and a tremendous amount of genetic engineering to get rapeseed oil to be acceptable to the US market.
The late 1970s introduced a technique of genetic treatment involving cracking open seeds. Canadian plant breeders developed a variation of rapeseed that produced a monounsaturated oil low in erucic acid.
The name was changed to LEAR: Low Eruric Acid Rapeseed. LEAR was not well received in the US as its association with rapeseed was too glaring. Not to mention having the word “rape” in a product name, which did not promote a healthy image.
In 1978 the food industry merged the words “Canada” and “ola” meaning oil – creating the name Canola Oil.
The Impact of Canola on the Food Industry
Prior to the late 1970s, the food oil industry collaborated with the American Heart Association, departments of nutrition at major universities and numerous government agencies to advocate polyunsaturated oils as being heart healthy. This was in contrast to the false hardening of the arteries effect of saturated fats.
However, by the late 1970s/early 80s, the cooking oil industry in North America had a huge dilemma. The consumption of polyunsaturated oils – corn and soybean oils in particular – were directly connected to numerous inflammatory health complications: namely cancer and heart disease.
Subsequently, as a result of this problem, the food industry had to discontinue using large volumes of polyunsaturated oils and no longer made claims of the oils being healthy.
Furthermore, manufacturers would not resume the use of traditional “healthy” saturated fats – butter, lard, tallow, palm oil and coconut oil mainly due to their narrow profit margins.
During the early 1980s canola oil began an initial marketing campaign in the United States. In order to receive a full green light to move forward, the oil needed GRAS (generally regarded as safe) approval from the US Food & Drug Administration (FDA).
GRAS rating awards typically go to food and herbal products with a history of no known adverse effects. However, canola oil was a new product that had no previous history (although it was associated with a banned product known for having lethal side effects). On the other hand, rapeseed oil was never granted GRAS approval.
A change in the regulation needed to take place before canola oil could be marketed in the US. We still do not know exactly what happened, but GRAS was granted to canola oil in 1985. The rumor mill churned such tales citing that the Canadian government, as a result, had a $50 million deficit in their coffers.
Originally canola oil was invented through basic laboratory breeding and selection techniques. Nevertheless, in 1995 a major alteration launched a canola that was genetically engineered to contain bacterial DNA that would make it resistant to toxic herbicides (Roundup).
Genetically modified crops are a combination of the DNA of two or more different species that cannot naturally reproduce together (like a chicken and a celery stalk). Such “frankenfood” could never occur in nature, even by random mutation. Today, most canola oil comes from genetically engineered seeds that are so far deviated from the natural rapeseed that it can be patented.
Around 82 percent of the world’s canola crops are currently genetically engineered to resist Roundup. Monsanto presently owns patents on the Roundup-Ready canola seed and farmers can be sued for not using the seed or having “unauthorized” canola plants in their fields.
It is also next to impossible for farmers (organic or otherwise) to battle the superweeds that are evolving in reaction to constant massive doses of Roundup.
Read the full article at The Truth about Cancer .
  The Footprint Family
  Dr. Leonard G. Horowitz – The Truth About Canola Oil
  The HealthWyze Report
  Small Footprint Family
  Dr. Axe – Food is Medicine
  Weston A. Price Foundation
  The Small Footprint Family
We Lost the War on Cancer – Review of Alternative Cancer Therapies
We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.
The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.
The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.
John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it in Part I. In Part II, he surveys the various alternative cancer therapies that have been proven effective, but that are not approved by the FDA.
Read We Lost the War on Cancer – Review of Alternative Cancer Therapies on your mobile device!
FREE! – $0.99